Search
Sanofi to Acquire Vicebio for Up to $1.6 Billion, Bolstering Its Entry into the Respiratory Virus Vaccine Market
2025-07-22 /
Read about 0 minute
Author：小编
Sanofi has entered into an agreement to acquire Vicebio, a leading biopharmaceutical company, for a total consideration of up to $1.6 billion. This includes an initial payment of $1.15 billion and potential milestone payments of up to $450 million, marking Sanofi's strategic entry into the respiratory virus vaccine sector.
-
C114 Communication Network -
Communication Home
7 X 24 Track global technological trends
